reversal antipsychotic-induced working memory deficits short-term doper d1 receptor stimulation
chronic blockade dopamine d2 receptors common mechanism action antipsychotic drugs down-regulates d1 receptors prefrontal cortex shown produces severe impairments working memory deficits reversed monkeys short-term coadministration d1 agonist abt improvement sustained year cessation d1 treatment findings indicate pharmacological modulation d1 signaling pathway can produce long-lasting changes functional circuits underlying working memory resetting pathway brief exposure agonist may provide valuable strategy therapeutic intervention schizophrenia dopamine dysfunctional states
